Suchergebnisse - "Magro, F"

PubPharm (11)

1

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients : Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study

enthalten in: Journal of Crohn's & colitis | 2019

von Magro, F. | Lopes, S. | Silva, M. | +18

2

Editorial : antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Goncalves, J. | Magro, F. | Danese, S. | +2

CommentOn: Aliment Pharmacol Ther. 2018 Sep;48(5):507-522. - PMID 29873091

3

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Goncalves, J. | Santos, M. | Acurcio, R. | +29

CommentIn: Aliment Pharmacol Ther. 2018 Sep;48(5):574-575. - PMID 30156324

4

Proactive therapeutic drug monitoring of infliximab : a comparative study of a new point-of-care quantitative test with two established ELISA assays

enthalten in: Alimentary pharmacology & therapeutics | 2016

von Afonso, J. | Lopes, S. | Gonçalves, R. | +11

5

Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection

enthalten in: Clinical and experimental immunology | 2014

von Nazareth, N. | Magro, F. | Silva, J. | +6

6

Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia : report of five cases and review of the literature

enthalten in: Dermatology (Basel, Switzerland) | 2012

von Osório, F. | Magro, F. | Lisboa, C. | +5

7

Severe gram positive bacterial infection in an ulcerative colitis patient treated with Infliximab

enthalten in: Journal of Crohn's & colitis | 2010

von Marques, M. | Rodrigues, S. | Mariz, E. | +6

8

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis

enthalten in: Inflammatory bowel diseases | 2008

von Marques, M. | Magro, F. | Cardoso, H. | +4

CommentIn: Inflamm Bowel Dis. 2011 Nov;17(11):E149-50. - PMID 21987301

9

Infliximab dose intensification by shortening infusion intervals

enthalten in: Inflammatory bowel diseases | 2008

von Magro, F. | Bastos, R. | Marques, M. | +1

10

Unusual presentation of tuberculosis after infliximab therapy

enthalten in: Inflammatory bowel diseases | 2005

von Magro, F. | Pereira, P. | Veloso, F. | +1